Table 2 Distributions of cardiovascular events in RA patients according to disease duration (<6 months: incident RA, ≥6 months: prevalent RA and IgM rheumatoid factor and/or anti-CCP positivity
Event type (n,%) | RA (n = 480) | Incident RA (n = 60) | Prevalent RA (n = 240) | Seronegative RA (n = 166) | Seropositive RA (n = 286) |
|---|---|---|---|---|---|
Myocardial infarction | 2 (6.9) | 1 (33.3) | 1 (3.8) | 1 (10.0) | 1 (5.9) |
Acute coronary syndrome | 10 (34.5) | 2 (66.6) | 9 (34.6) | 4 (40.0) | 7 (41.2) |
Acute heart failure | 4 (13.8) | 0 (0.0) | 4 (15.4) | 1 (10.0) | 2 (11.8) |
Coronary intervention | 5 (17.2) | 0 (0.0) | 5 (17.2) | 2 (20.0) | 2 (11.8) |
Cerebrovascular accident | 5 (17.2) | 0 (0.0) | 5 (17.2) | 1 (10.0) | 4 (23.5) |
Cardiac death | 2 (6.9) | 0 (0.0) | 2 (7.7) | 1 (10.0) | 1 (5.9) |
All | 29 (100) | 3 (100) | 26 (100) | 10 (100) | 17 (100) |
All, events/1000 py | 21 | 18 | 21 | 20 | 21 |